Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki DiseaseHemic and Lymphatic Diseases, Kawasaki disease, Skin and Connective Tissue Diseases, cardiovascular disorder, lymphatic system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitisNot yet recruitingPhase 2 / Phase 32026-07-27NCT07686770

2 results · Page 1 of 1

Swipe the table sideways for more columns.

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Children's Hospital of Fudan UniversityShanghaiChina34
Jiangxi Provincial Children's HospitalNanchangChina2